Vaccine Shows Promise in Treating High Blood Sugar for Those With Long COVID
August 21, 2024
August 21, 2024
NEW ORLEANS, Louisiana, Aug. 21 (TNSres) -- Tulane University issued the following news release:
Researchers at Tulane University have discovered a new approach to tackling a lingering health challenge faced by some with long-term COVID: high blood sugar levels. A new study published in Nature Communications and conducted at the Tulane National Primate Research Center suggests that the COVID-19 vaccine could be used therapeutically to address metabolic complications experienced amon . . .
Researchers at Tulane University have discovered a new approach to tackling a lingering health challenge faced by some with long-term COVID: high blood sugar levels. A new study published in Nature Communications and conducted at the Tulane National Primate Research Center suggests that the COVID-19 vaccine could be used therapeutically to address metabolic complications experienced amon . . .